Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biodetection

    NASA Seeks Point-of-Care Diagnostic System

    By Stephanie LizotteMarch 21, 2012
    Share
    Facebook LinkedIn Reddit Email

    NASA Glenn Research Center is soliciting information about potential sources for a Point of Care (POC) Diagnostics system that can be developed in support of flight research on the International Space Station (ISS).

    With the retirement of the Space Shuttle, biological sample return from the ISS will be challenging due to volume limitations. Rather than relying on sample return and ground-based analysis, in-flight analysis will provide point of care assessment of analytes of interest to the NASA biomedical research community.

    The requirement for potential in-flight lab analysis technologies specifies four high priority analytes targeted to demonstrate the technology: Vitamin-D, N-Telopeptide, interferon gamma, and tumor necrosis factor alpha. Within the scope of any funded effort, the initial four analytes are to be measured and validated against current laboratory gold standards, such as ELISA.

    NASA has additionally detailed an expanded set of high priority analytes to assess extensibility of the technology. Companies are requested to provide information on the feasibility, development time and future potential for expanding the platform to include these forty-three other bone, immune, hormone and oxidative stress biomarkers (listed in the solicitation).

    Anticipated goals during the 12-month contract include (for all four assays) assay feasibility, assay validation against a recognized laboratory standard, a multiplexed demonstration of all four assays, and an on-site demonstration.

    Minimum validation will include simultaneous testing of no less than n=6 human serum samples. Though it is not required, the proposer is encouraged to develop the analytes in whole human blood, whereby no less than n=6 test subjects provide whole blood samples in the laboratory. Where serum is used as a sample, the proposal shall delineate the necessary steps to preprocess whole human blood to an acceptable sample that is ready for testing, while being mindful that the in-flight operational concept is to minimize and simplify procedural steps from crewmember blood draw (finger prick) to analysis.

    The technology sought should not be precluded from operating in zero-gravity and any proposal is required to provide rationale as to why the device would be able to be operable in a space environment.

    Should a Request For Proposal (RFP) result from this information-gathering action, the estimated award date for the contract is fall of 2012. Full details are available under NASA Soliciation NNC12ZMS016L. The deadline for response is April 9, 2012.

    Biomarkers Multiplex POC Diagnostics RFI
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleDoD Seeks New Drug for Alphaviruses
    Next Article UMDNJ, Cepheid Working Together to Advance Bloodstream Bacteria Diagnostics

    Related Stories

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    Mass Spec for Rapid Detection of Biological Warfare Agents

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy